| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |